TAGCyx Biotechnologies Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 20
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $1.86M
Latest Deal Amount
  • Investors
  • 5

TAGCyx Biotechnologies General Information

Description

Developer of a drug discovery platform designed to identify and develop novel nucleic acid-based drugs. The company's platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications, enabling doctors in proper treatment of diseases.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Tokyo University Komaba Open Laboratory Number 403
  • 4-6-1 Komaba, Meguro-ku
  • Tokyo, Tokyo 153-0041
  • Japan

TAGCyx Biotechnologies Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TAGCyx Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 05-May-2020 $1.86M 000.00 Completed Generating Revenue
2. Later Stage VC 27-Apr-2018 00.000 00.00 Completed Generating Revenue
1. Later Stage VC 31-Aug-2016 $4.94M $4.94M Completed Startup
To view TAGCyx Biotechnologies’s complete valuation and funding history, request access »

TAGCyx Biotechnologies Executive Team (4)

Name Title Board Seat Contact Info
Chizuko Koseki Ph.D Representative Director, President & Chief Executive Officer
Akiyoshi Kudose Chief Financial Officer & Board Member
Susumu Muto Chief Scientific Officer & Board Member
Katsunori Suzuki Board Member & Auditor
To view TAGCyx Biotechnologies’s complete executive team members history, request access »

TAGCyx Biotechnologies Board Members (9)

Name Representing Role Since
Akinori Mochizuki Ph.D Self Board Member 000 0000
Akiyoshi Kudose TAGCyx Biotechnologies Chief Financial Officer & Board Member 000 0000
Junya Yamazaki The University of Tokyo Edge Capital Board Member 000 0000
Katsunori Suzuki Self Board Member & Auditor 000 0000
Maiko Katadae Ph.D The University of Tokyo Edge Capital Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

TAGCyx Biotechnologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TAGCyx Biotechnologies Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mizuho Capital Partners Venture Capital Minority 000 0000 000000 0
UTokyo Innovation Platform Venture Capital Minority 000 0000 000000 0
Nissay Capital Venture Capital Minority 000 0000 000000 0
SMBC Venture Capital Venture Capital Minority 000 0000 000000 0
The University of Tokyo Edge Capital Venture Capital Minority 000 0000 000000 0
To view TAGCyx Biotechnologies’s complete investors history, request access »